1H MRSI of middle frontal gyrus in pediatric ADHD

Journal of Psychiatric Research

Volumn 47, Issue 4, 2013, Pages 505-512

  Tafazoli, Sharwin ^b   O'Neill, Joseph ^a   Bejjani, Anthony ^a   Ly, Ronald ^a   Salamon, Noriko ^c   McCracken, James T ^c   Alger, Jeffry R ^c,d   Levitt, Jennifer G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ahmanson Lovelace Brain Mapping Center in the Department of Neurology   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d Interdepartmental Program for Biomedical Engineering   (United States)

Author keywords

Choline compounds; Creatine; Dorsolateral prefrontal cortex; Myo inositol; N acetyl aspartate

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; INOSITOL; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

ADOLESCENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN PERFUSION; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; MALE; MIDDLE FRONTAL GYRUS; NEUROIMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD; TRAIL MAKING TASK; ANALYSIS OF VARIANCE; IMAGE PROCESSING; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREFRONTAL CORTEX;

ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHOLINE; CREATINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREFRONTAL CORTEX;

EID: 84874490571     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.11.011     Document Type: Article

References (72)

1. Amen D.G., Carmichael B.D. High-resolution brain SPECT imaging in ADHD. Annals of Clinical Psychiatry 1997, 9:81-86.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Text-Revision, American Psychiatric Association, Washington, DC. 4th ed.
3. Aron A.R., Fletcher P.C., Bullmore E.T., Sahakian B.J., Robbins T.W. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry 2003, 54:1465-1468.
4. Barkley R.A., Grodzinsky G. Are tests of frontal lobe functions useful in the diagnosis of attention deficit disorders?. Clinical Neuropsychology 1994, 8:121-139.
5. Barnett R., Maruff P., Vance A. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders. Australian and New Zealand Journal of Psychiatry 2009, 43:722-730.
6. Bedard A.C., Ickowicz A., Tannock R. Methylphenidate improves Stroop named speed, but not response interference, in children with attention-deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 2002, 12:301-309.
7. Bedard A.C., Ickowicz A., Logan G.D., Hogg-Johnson S., Schachar R., Tannock R. Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. Journal of Abnormal Child Psychology 2003, 31:315-327.
8. Blanton R.E., Levitt J.G., Peterson J.R., Fadale D., Sporty M.L., Lee M., et al. Gender differences in the left inferior frontal gyrus in normal children. NeuroImage 2004, 22:626-636.
9. Carrey N., MacMaster F.P., Fogel J., Sparkes S., Waschbusch D., Sullivan S., et al. Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study. Clinical Neuropharmacology 2003, 26:218-221.
10. Carrey N.J., MacMaster F.P., Gaudet L., Schmidt M.H. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 2007, 17:11-17.
11. Cheon K.A., Ryu Y.H., Kim Y.K., Namkoong K., Kim C.H., Lee J.D. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder. European Journal of Nuclear Medicine and Molecular Imaging 2003, 30:306-311.
12. Colla M., Ende G., Alm B., Deuschle M., Heuser I., Kronenberg G. Cognitive MR spectroscopy of anterior cingulate cortex in ADHD: elevated choline signal correlates with slowed hit reaction times. Journal of Psychiatric Research 2008, 42:587-595.
13. Courvoisie H., Hooper S., Fine C., Kwock L., Castillo M. Neurometabolic functioning and Neuropsychological correlates in children with ADHD. Journal of Neuropsychiatry and Clinical Neuroscience 2004, 16:63-69.
14. Epstein J.N., Delbello M.P., Adler C.M., Altaye M., Kramer M., Mills N.P., et al. Differential patterns of brain activation over time in adolescents with and without attention deficit hyperactivity disorder (ADHD) during performance of a sustained attention task. Neuropediatrics 2009, 40:1-5.
15. Ernst M., Kimes A.S., London E.D., Matochik J.A., Eldreth D., Tata S., et al. Neural substrates of decision making in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry 2003, 160:1061-1070.
16. Fayed N., Modergo P.J. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Academy of Radiology 2005, 12:566-569.
17. Fleet W.S., Valenstein E., Watson R.T., Heilman K.M. Dopamine agonist therapy for neglect in humans. Neurology 1987, 37:1765-1770.
18. Gau S.S., Chiu C.D., Shang C.Y., Cheng A.T., Soong W.T. Executive function in adolescence among children with attention-deficit/hyperactivity disorder in Taiwan. Journal of Developmental and Behavioral Pediatrics 2009, 30:525-534.
19. Gau S.S., Shang C.Y. Executive functions as endophenotypes in ADHD: evidence from the Cambridge Neuropsychological Test Battery (CANTAB). Journal of Child Psychology and Psychiatry 2010, 51:838-849.
20. Helinger B., Thiel T., Elst L., Hennig J., Ebert D. Attention-deficit disorder in adults with or without hyperactivity: where is the difference? A study in humans using short echo H-magnetic resonance spectroscopy. Neuroscience Letters 2001, 304:117-119.
21. Iversen S.D. Behavioural effects of manipulation of basal ganglia neurotransmitters. Ciba Foundation Symposium 1984, 107:183-200.
22. Jensen P.S., Hinshaw S.P., Swanson J.M., Greenhill L.L., Conners C.K., Arnold L.E., et al. Findings from the NIMH multimodal treatment study of ADHD (MTA): implications and applications for primary care providers. Journal of Developmental and Behavioral Pediatrics 2001, 22:60-73.
23. Kaya G.C., Pekcanlur A., Beki{dotless}s R., Ada E., Mi{dotless}ral S., Emiroĝlu N., et al. Technetium-99m HMPAO brain SPECT in children with attention deficit hyperactivity disorder. Annals of Nuclear Medicine 2002, 16:527-531.
24. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C., Demler O., et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. American Journal of Psychiatry 2006, 163:716-723.
25. Kim B.-N., Kim J.-W., Kang H., Cho S.-C., Shin M.-S., Yoo H.-J., et al. Regional differences in cerebral perfusion associated with the α-2A-adrenergic receptor genotypes in attention deficit hyperactivity disorder. Journal of Psychiatry and Neurosciences 2010, 35(5):330-336.
26. Kim B.-N., Lee J.-S., Shin M.-S., Cho S.-C., Lee D.-S. Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder: statistical parametric mapping analysis. European Archives of Psychiatry and Clinical Neuroscience 2002, 252:219-225.
27. Kronenberg G., Ende G., Alm B., Deuschle M., Heuser I., Colla M. Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate: a spectroscopic test-retest study in adult ADHD. European Archives of Psychiatry and Clinical Neuroscience 2008, 258:446-450.
28. Laakso A., Vilkman H., Alakare B., Haaparanta M., Bergman J., Solin O., et al. Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. American Journal of Psychiatry 2000, 157:269-271.
29. Larisch R., Meyer W., Klimke A., Kehren F., Vosberg H., Müller-Gärtner H.W. Left-right asymmetry of striatal dopamine D2 receptors. Nuclear Medicine Communications 1998, 19:781-787.
30. Leontiev O., Dubowitz D.J., Buxton R.B. CBF/CMRO2 coupling measured with calibrated-BOLD fMRI: sources of bias. Neuroimage 2007, 15(36):1110-1122.
31. Liew A., Yan H. Current methods in the automatic tissue segmentation of 3D magnetic resonance brain images. Current Medical Imaging Reviews 2006, 2:3-4.
32. Loo S.K., Hopfer C., Teale P.D., Reite M.L. EEG correlates of methylphenidate response in ADHD: association with cognitive and behavioral measures. Journal of Clinical Neurophysiology 2004, 21:457-464.
33. Lorberboym M., Watemberg N., Nissenkorn A., Batia N., Lerman-Sagie T. Technetium 99m ethylcysteinate dimer SPECT during intellectual stress test in children and adolescents with pure versus comorbid ADHD. Journal of Child Neurology 2004, 19:91-96.
34. MacMaster F.P., Carrey N., Sparkes S., Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biological Psychiatry 2003, 53:184-187.
35. McCracken J.T. Neuropsychiatric aspects of attention deficit hyperactivity disorder. Textbook of pediatric neuropsychiatry 1998, 438-502. American Psychiatric Association Press. E. Coffey, S. Brumbach (Eds.).
36. Mehta M.A., Owen A.M., Sahakian B.J., Mavaddat N., Pickard J.D., Robbins T.W. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. Journal of Neuroscience 2000, 20:1-6.
37. Makris N., Biederman J., Valera E.M., Bush G., Kaiser J., Kennedy D.N., et al. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cerebral Cortex 2007, 17:1364-1375.
38. Mesulam M.M. A cortical network for directed attention and unilateral neglect. Annals of Neurology 1981, 10:309-325.
39. Moll J., Oliveira-Souza R.R., Moll F.T., Bramati I.E., Andreiuolo P.A. The cerebral correlates of set-shifting: an fMRI study of the trail making test. Arquivos de Neuro-Psiquiatria 2002, 60:900-905.
40. Moser D.J., Jorge R.E., Manes F., Paradiso S., Benjamin M.L., Robinson R.G. Improved executive functioning following repetitive transcranial magnetic stimulation. Neurology 2002, 58:1288-1290.
41. Narr K.L., Woods R.P., Lin J., Kim J., Phillips O.R., Del'Homme M., et al. Widespread cortical thinning is a robust anatomical marker for attention deficit/hyperactivity disorder (ADHD). Journal of the American Academy of Child and Adolescent Psychiatry 2009, 48:1014-1022.
42. Nigg J.T., Swanson J.M., Hinshaw S.P. Covert visual spatial attention in boys with attention deficit hyperactivity disorder: lateral effects, methylphenidate response, and results for parents. Neuropsychologia 1997, 35:165-176.
43. O'Gorman R.L., Mehta M.A., Asherson P., Zelaya F.O., Brookes K.J., Toone B.K., et al. Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalized by stimulant treatment: a non-invasive MRI pilot study. Neuroimage 2009, 42:36-41.
44. O'Neill J, Levitt J, Alger JR. Magnetic resonance spectroscopy studies of attention deficit hyperactivity disorder. In: Bluml S., Panigrahy A., editors. MR spectroscopy of pediatric brain disorders. New York: Springer, in press.
45. O'Neill J, Tseng PB, Pagare R, Frew AJ, Tafazoli S, Alger JR. MRSI Voxel Picker (MVP): software for co-evaluation of structural and spectroscopic information. ISMRM WorkShop on Quantitative Spectroscopy, 2006.
46. Owen A.M., Evans A.C., Petrides M. Evidence for a two-stage model of spatial working memory processing within lateral frontal cortex: a positron emission tomography study. Cerebral Cortex 1996, 6:31-38.
47. Perlov E., Philipsen A., Hesslinger B., Buechert M., Ahrendts J., Feige B., et al. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder - a magnet resonance spectroscopy study. Journal of Psychiatric Research 2007, 41:934-941.
48. Perlov E., Philipsen A., Matthies S., Drieling T., Maier S., Bubl E., et al. Spectroscopic findings in attention-deficit/hyperactivity disorder: review and meta-analysis. World Journal of Biological Psychiatry 2009, 10:355-365.
49. Provencher S.W. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR in Biomedicine 2001, 14:260-264.
50. Reitan R.M. Manual for administration of neuropsychological test battery for adults and children 1979, Neuropsychology Laboratory, Tucson, AZ.
51. Ross B., Bluml S. Magnetic resonance spectroscopy of the human brain. The Anatomical Record 2001, 265:54-84.
52. Russell V., Oades R., Tannock R., Killeen P.R., Auerbach J.G., Johansen E.B., et al. Response variability in ADHD: a neuronal and glial energetic hypothesis. Behavioral and Brain Functions 2006, 6-25.
53. Seeman P., Madras B.K. Anti-hyperactivity medication: methylphenidate and amphetamine. Molecular Psychiatry 1998, 3:386-396.
54. Seese R.R., O'Neill J., Hudkins M., Siddarth P., Levitt J., Tseng B., et al. Proton magnetic resonance spectroscopy and thought disorder in childhood schizophrenia. Schizophrenia Research 2011, 133:82-90.
55. Shattuck D.W., Sandor-Leahy S.R., Schaper K.A., Rottenberg D.A., Leahy R.M. Magnetic resonance image tissue classification using a partial volume model. NeuroImage 2001, 856-876.
56. Shaw P., Lerch J., Greenstein D., Sharp W., Clasen L., Evans A., et al. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Archives Gen Psychiatry 2006, 63:540-549.
57. Sheppard D.M., Bradshaw J.L., Mattingley J.B., Lee P. Effects of stimulant medication on the lateralization of line bisection judgments of children with attention deficit hyperactivity disorder. Journal of Neurology, Neurosurgery, and Psychiatry 1999, 66:57-63.
58. Soliva J.C., Moreno A., Fauqet J., Carmona S., Gispert J., Rovira M., et al. Cerebellar neurometabolite abnormalities in pediatric attention/deficit hyperactive disorder. Neuroscience Letters 2010, 470:60-64.
59. Spalletta G., Pasini A., Pau F., Guido G., Menghini L., Caltagirone C. Prefrontal blood flow dysregulation in drug naïve ADHD children without structural abnormalities. Journal of Neural Transmission 2001, 108:1203-1216.
60. Sparkes S.J., MacMaster F.P., Carrey N.C. Proton magnetic resonance spectroscopy and cognitive function in pediatric attention-deficit/hyperactive disorder. Brain and Cognition 2001, 174:173-175.
61. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Molecular Psychiatry 2005, 10:900-919.
62. Taylor J.L., Blanton R.E., Levitt J.G., Caplan R., Nobel N., Toga A.W. Superior temporal gyrus differences in childhood-onset schizophrenia. Schizophrenia Research 2005, 73:235-241.
63. Todd R.D., Botteron K.N. Is ADHD an energy deficiency syndrome?. Biological Psychiatry 2001, 50:151-158.
64. Urrila A.S., Hakkarainen A., Heikkinen S., Vuori K., Stenberg D., Häkkinen A.-M., et al. Metabolic imaging of human cognition: an fMRI/1H-MRS study of brain lactate response to silent word generation. Journal of Cerebral Blood Flow and Metabolism 2003, 23:942-948.
65. Voeller K.K., Heilman K.M. Attention deficit disorder in children: a neglect syndrome?. Neurology 1988, 38:806-808.
66. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. American Journal of Psychiatry 1998, 155:1325-1331.
67. Weber P., Lütschg J., Fahnenstich H. Cerebral hemodynamic changes in response to an executive function task in children with attention-deficit hyperactivity disorder measured by near-infrared spectroscopy. Developmental and Behavioral Pediatrics 2005, 26:105-111.
68. Weber P., Lütschg J., Fahnenstich H. Methylphenidate-induced changes in cerebral hemodynamics measured by functional near-infrared spectroscopy. Journal of Child Neurology 2007, 22:812-817.
69. Wechsler D. Manual for the Wechsler Intelligence scale for children 1974, Revised, The Psychological Corporation, New York.
70. Yang H., Wu Q.Z., Guo L.T., Li Q.Q., Long X.Y., Huang X.Q., et al. Abnormal spontaneous brain activity in medication-naïve ADHD children: a resting state fMRI study. Neuroscience Letters 2011, 502:89-93.
71. Yeo R.A., Hill D.E., Campbell R.A., Vigil J., Petropoulos H., Hart B., et al. Proton magnetic resonance spectroscopy investigation of the right frontal lobe in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2003, 42:303-310.
72. Zakzanis K.K., Mraz R., Graham S.J. An fMRI study of the trail making test. Neuropsychologia 2005, 43:1878-1886.